Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome

Human Reproduction

Volumn 21, Issue 2, 2006, Pages 457-465

  Palomba, Stefano ^a   Russo, Tiziana ^a   Orio Jr , Francesco ^b   Falbo, Angela ^a   Manguso, Francesco ^b   Cascella, Teresa ^b   Tolino, Achille ^b   Carmina, Enrico ^c   Colao, Annamaria ^b   Zullo, Fulvio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Anovulation; Endometrium; Metformin; PCOS; Ultrasound

Indexed keywords

METFORMIN; PROGESTERONE;

ADULT; AGE DISTRIBUTION; ANALYTICAL PARAMETERS; ANOVULATION; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG DOSE REGIMEN; DRUG EFFICACY; ECHOGRAPHY; ENDOMETRIUM; FEMALE; HUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; REPRODUCTION; STATISTICAL SIGNIFICANCE; THICKNESS; TREATMENT OUTCOME; UTERUS BLOOD FLOW;

EID: 31544442962     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei351     Document Type: Article

References (68)

1. Ajossa S, Paoletti AM, Guerriero S, Floris S, Mannias M and Melis GB (1999) Effect of chronic administration of cabergoline on uterine perfusion in women with polycystic ovary syndrome. Fertil Steril 71,314-318.
2. Ajossa S, Guerriero S, Paoletti AM, Orru M and Melis GB (2002) The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome. Fertil Steril 77,1136-1140.
3. Aleem FA and Predanic M (1996) Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease. Fertil Steril 65,510-516.
4. Apparao KB, Lovely LP, Gui Y, Lininger RA and Lessey BA (2002) Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod 66,297-304.
5. Balen AH, Laven JS, Tan SL and Dewailly D (2003) Ultrasound assessment of the polycystic ovary: International consensus definitions. Hum Reprod Update 9,505-514.
6. Barnett SB, Ter Haar GR, Ziskin MC, Rott HD, Duck FA and Maeda K (2000) International recommendations and guidelines for the safe use of diagnostic ultrasound in medicine. Ultrasound Med Biol 26,355-366.
7. Barros LF, Yudilevich DL, Jarvis SM, Beaumont N and Baldwin SA (1995) Quantitation and immunolocalisation of glucose transporters in the human placenta. Placenta 16,623-633.
8. Basir GS, Lam TP, Chau MT, Ng EH, O WS and Ho PC (2001) Colour Doppler analysis of peri-implantation utero-ovarian haemodynamics in women with excessively high oestradiol concentrations after ovarian stimulation. Hum Reprod 16,2114-2117.
9. Battaglia C, Artini PG, D'Ambrogio G, Genazzani AD and Genazzani AR (1995) The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol 172,108-113.
10. Battaglia C, Artini PG, Genazzani AD, Sgherzi MR, Salvatori M, Giulini S and Volpe A (1996) Color Doppler analysis in lean and obese women with polycystic ovary syndrome. Ultrasound Obstet Gynecol 7,342-346.
11. Battaglia C, Artini PG, Genazzani AD, Gremigni R, Salvatori M, Sgherzi MR, Giulini S, Lombardo M and Volpe A (1997) Color Doppler analysis in oligo- and amenorrheic women with polycystic ovary syndrome. Gynecol Endocrinol 11,105-110.
12. Cacciatore B, Simberg N, Fusaro P and Tiitinen A (1996) Transvaginal Doppler study of uterine artery blood flow in in vitro fertilization-embryo transfer cycles. Fertil Steril 66,130-134.
13. Cacciatore B, Simberg N, Tiitinen A and Ylikorkala O (1997) Evidence of interplay between plasma endothelin-1 and 17 beta-estradiol in regulation of uterine blood flow and endometrial growth in infertile women. Fertil Steril 67,883-888.
14. Cermik D, Selam B and Taylor HS (2003) Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 88,238-243.
15. Chien LW, Au HK, Chen PL, Xiao J and Tzeng CR (2002) Assessment of uterine receptivity by the endometrial-subendometrial blood flow distribution pattern in women undergoing in vitro fertilization-embryo transfer. Fertil Steril 78,245-251.
16. Dastidar KG and Dastidar SG (2003) Dynamics of endometrial thickness over time: A reappraisal to standardize ultrasonographic measurements in an infertility program. Fertil Steril 80,213-215.
17. Dickey RP (1997) Doppler ultrasound investigation of uterine and ovarian blood flow in infertility and early pregnancy. Hum Reprod Update 3,467-503.
18. Dickey RP and Holtkamp DE (1996) Development, pharmacology and clinical experience with clomiphene citrate. Hum Reprod Update 2,483-506.
19. Dickey RP, Olar TT, Taylor SN, Curole DN and Matulich EM (1993) Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: Effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertil Steril 59,756-760.
20. Doherty CM, Silver B, Binor Z, Molo MW and Radwanska E (1993) Transvaginal ultrasonography and the assessment of luteal phase endometrium. Am J Obstet Gynecol 168,1702-1707.
21. Economos K, MacDonald PC and Casey ML (1992) Endothelin-1 gene expression and protein biosynthesis in human endometrium: Potential modulator of endometrial blood flow. J Clin Endocrinol Metab 74,14-19.
22. Fanchin R, Righini C, Ayoubi JM, Olivennes F, de Ziegler D and Frydman R (2000) New look at endometrial echogenicity: Objective computer-assisted measurements predict endometrial receptivity in in vitro fertilization-embryo transfer. Fertil Steril 74,274-281.
23. Fischer GM and Swain ML (1977) Effect of sex hormones on blood pressure and vascular connective tissue in castrated and noncastrated male rats. Am J Physiol 232,H617-621.
24. Friedler S, Schenker JG, Herman A and Lewin A (1996) The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: A critical review. Hum Reprod Update 2,323-235.
25. Gonen Y and Casper RF (1990a) Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 5,670-674.
26. Gonen Y and Casper RF (1990b) Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF). J In Vitro Fertil Embryo Transfer 7,146-152.
27. Goswamy RK, Williams G and Steptoe PC (1988) Decreased uterine perfusion - a cause of infertility. Hum Reprod 3,955-959.
28. Habara T, Nakatsuka M, Konishi H, Asagiri K, Noguchi S and Kudo T (2002) Elevated blood flow resistance in uterine arteries of women with unexplained recurrent pregnancy loss. Hum Reprod 17,190-194.
29. Hackl H (1973) Metabolism of glucose in the human endometrium with special reference to fertility and contraception. Acta Obstet Gynecol Scand 52,135-140.
30. Hock DL, Bohrer MK, Ananth CV and Kemmann E (1997) Sonographic assessment of endometrial pattern and thickness in patients treated with clomiphene citrate, human menopausal gonadotropins, and intrauterine insemination. Fertil Steril 68,242-245.
31. Jakubowicz DJ, Seppala M, Jakubowicz S, Rodriguez-Armas O, Rivas-Santiago A, Koistinen H, Koistinen R and Nestler JE (2001) Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab 86,1126-1133.
32. Jansson T, Wennergren M and Illsley NP (1993) Glucose transporter expression and distribution in the human placenta throughout gestation and in intrauterine growth retardation. J Clin Endocrinol Metab 77,1554-1562.
33. Kashyap S, Wells GA and Rosenwaks Z (2004) Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome. Hum Reprod 19,2474-2483.
34. Kocak M, Caliskan E, Simsir C and Haberal A (2002) Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 77,101-106.
35. Korgun ET, Denir R, Hammer A, Dohr G, Desoye G, Skofitch G and Hahn T (2001) Glucose transporter expression in rat embryo and uterus during decidualization, implantation, and early postimplantation. Biol Reprod 65,1364-1370.
36. Kurjak A, Kupesic-Urek S, Schulman H and Zalud I (1991) Transvaginal color flow Doppler in the assessment of ovarian and uterine blood flow in infertile women. Fertil Steril 56,870-873.
37. Lord JM, Flight IH and Norman RJ (2003) Metformin in polycystic ovary syndrome: Systematic review and meta-analysis. Br Med J 327,951-953.
38. Mioni R, Chiarelli S, Xamin N, Zuliani L, Granzotto M, Mozzanega B, Maffei P, Martini C, Blandamura S, Sicolo N et al (2004) Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients. J Clin Endocrinol Metab 89,4089-4096.
39. Nakamura Y, Ono M, Yoshida Y, Sugino N, Ueda K and Kato H (1997) Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertil Steril 67,256-260.
40. Nestler JE and Jakubowicz DJ (1996) Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction in insulin secretion in women with polycystic ovary syndrome. New Engl J Med 335,617-623.
41. Noyes RW and Haman JO (1953) Accuracy of endometrial dating; correlation of endometrial dating with basal body temperature and menses. Fertil Steril 4,504-517.
42. Orio F Jr, Palomba S, Cascella T, De Simone B, Di Biase S, Russo T, Labella D, Zullo F, Lombardi G and Colao A (2004) Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 89,4588-4593.
43. Orio F Jr, Palomba S, Cascella T, De Simone B, Manguso F, Savastano S, Russo T, Tolino A, Zullo F, Lombardi G et al (2005) Improvement of endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a six-month pilot study. J Clin Endocrinol Metab, Aug 23 (Epub ahead of print).
44. Palomba S, Orio F Jr, Colao A, di Carlo C, Sena T, Lombardi G, Zullo F and Mastrantonio P (2002) Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis. J Clin Endocrinol Metab 87,1502-1508.
45. Palomba S, Orio F Jr, Russo T, Falbo A, Cascella T, Colao A, Lombardi G and Zullo F (2004a) Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome? J Endocrinol Invest 27,796-805.
46. Palomba S, Orio F Jr, Nardo LG, Falbo A, Russo T, Corea D, Doldo P, Lombardi G, Tolino A, Colao A and Zullo F (2004b) Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: A prospective parallel randomized double-blind placebo-controlled trial. J Clin Endocrinol Metab 89,4801-4809.
47. Palomba S, Orio F Jr, Falbo A, Manguso F, Russo T, Cascella T, Tolino A, Carmina E, Colao A and Zullo F (2005a) Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90,4068-4074.
48. Palomba S, Orio F jr, Falbo A, Russo T, Tolino A and Zullo F (2005b) Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome. Fertil Steril, 84,761-765.
49. Pierson RA (2003) Imaging the endometrium: Are there predictors of uterine receptivity? J Obstet Gynaecol Can 25,360-368.
50. Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheugt FW and Gooren LJ (1993) Influence of sex hormones on plasma endothelin levels. Ann Intern Med 118,429-432.
51. Schwartz LB, Chiu AS, Courtney M, Krey L and Schmidt-Sarosi C (1997) The embryo versus endometrium controversy revisited as it relates to predicting pregnancy outcome in in-vitro fertilization-embryo transfer cycles. Hum Reprod 12,45-50.
52. Steer CV, Campbell S, Tan SL, Crayford T, Mills C, Mason BA and Collins WP (1992) The use of transvaginal color flow imaging after in vitro fertilization to identify optimum uterine conditions before embryo transfer. Fertil Steril 57,372-376.
53. Steer CV, Tan SL, Mason BA and Campbell S (1994) Midluteal-phase vaginal color Doppler assessment of uterine artery impedance in a subfertile population. Fertil Steril 61,53-58.
54. Straus DS (1984) Growth-stimulatory actions of insulin in vitro and in vivo. Endocr Rev 5,356-369.
55. Strowitzki T, Corleta Von Eye H, Kellerer M and Häring HU (1993) Tyrosine kinase activity of insulin like growth factors I and insulin receptors in human endometrium during the menstrual cycle: Cyclic variation of insulin receptor expression. Fertil Steril 59,315-322.
56. Strowitzki T, Capp E, von Wolff M and Mùller-Hòcker J (2001) Expression of glucose transporter 1 in human endometrial and decidual tissue. Gynecol Endocrinol 15,219-224.
57. Taylor HS (2000) The role of HOX genes in human implantation. Hum Reprod Update 6,75-79.
58. Tekay A, Martikainen H and Jouppila P (1996) Comparison of uterine blood flow characteristics between spontaneous and stimulated cycles before embryo transfer. Hum Reprod 11,364-368.
59. Tohma H, Hasegawa I, Sekizuka N and Tanaka K (1997) Uterine blood flow. Assessment in an intrauterine insemination program for unexplained infertility. J Reprod Med 42,463-466.
60. Triwitayakorn A, Suwajanakorn S, Triratanachat S, Sampatanukul P, Pruksananonda K and Sereepapong W (2002) Effects of initiation day of clomiphene citrate on the endometrium of women with regular menstrual cycles. Fertil Steril 78,102-107.
61. Tropea A, Miceli F, Minici F, Orlando M, Lamanna G, Gangale M, Catino S, Lanzone A and Apa R (2004) Endometrial evaluation in superovulation programs: Relationship with successful outcome. Ann NY Acad Sci 1034,211-218.
62. Truchan B, Taylor P, Goren HJ, Lederis K, Hollenberg MD and Okabe T (1987) Basal, oxytocin- and insulin-stimulated glucose oxidation in human endometrium. Can J Physiol Pharmacol 65,323-327.
63. Vrtacnik-Bokal E and Meden-Vrtovec H (1998) Utero-ovarian arterial blood flow and hormonal profile in patients with polycystic ovary syndrome. Hum Reprod 13,815-821.
64. Yaman C, Ebner T, Sommergruber M, Polz W and Tews G (2000) Role of three-dimensional ultrasonographic measurement of endometrium volume as a predictor of pregnancy outcome in an IVF-ET program: A preliminary study. Fertil Steril 74,797-801.
65. Ylikorkala O, Orpana A, Puolakka J, Pyorala T and Viinikka L (1995) Post-menopausal hormonal replacement decreases plasma levels of endothelin-1. J Clin Endocrinol Metab 80,3384-3387.
66. Zaidi J, Jurkovic D, Campbell S, Pittrof R, McGregor A and Tan SL (1995a) Description of circadian rhythm in uterine artery blood flow during the periovulatory period. Hum Reprod 10,1642-1646.
67. Zaidi J, Campbell S, Pittrof R and Tan SL (1995b) Endometrial thickness, morphology, vascular penetration and velocimetry in predicting implantation in an in vitro fertilization program. Ultrasound Obstet Gynecol 6,191-198.
68. Zawadzki JK and Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In Dunaif A, Givens JR, Haseltine FP and Merriam GR (eds) Polycystic Ovary Syndrome. Blackwell, Boston, pp 337-384.